Literature DB >> 24939653

A numerical method for analysis of in vitro time-dependent inhibition data. Part 2. Application to experimental data.

Ken Korzekwa1, Donald Tweedie1, Upendra A Argikar1, Andrea Whitcher-Johnstone1, Leslie Bell1, Shari Bickford1, Swati Nagar2.   

Abstract

Time-dependent inhibition (TDI) of cytochrome P450 enzymes is an important cause of drug-drug interactions. The standard approach to characterize the kinetics of TDI is to determine the rate of enzyme loss, kobs, at various inhibitor concentrations, [I], and replot the kobs versus [I] to obtain the key kinetic parameters, KI and kinact. In our companion manuscript (Part 1; Nagar et al., 2014) in this issue of Drug Metabolism and Disposition, we used simulated datasets to develop and test a new numerical method to analyze in vitro TDI data. Here, we have applied this numerical method to five TDI datasets. Experimental datasets include the inactivation of CYP2B6, CYP2C8, and CYP3A4. None of the datasets exhibited Michaelis-Menten-only kinetics, and the numerical method allowed use of more complex models to fit each dataset. Quasi-irreversible as well as partial inhibition kinetics were observed and parameterized. Three datasets required the use of a multiple-inhibitor binding model. The mechanistic and clinical implications provided by these analyses are discussed. Together with the results in Part 1, we have developed and applied a new numerical method for analysis of in vitro TDI data. This method appears to be generally applicable to model in vitro TDI data with atypical and complex kinetic schemes.
Copyright © 2014 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24939653      PMCID: PMC4152872          DOI: 10.1124/dmd.114.058297

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  41 in total

Review 1.  Crystallization of cytochromes P450 and substrate-enzyme interactions.

Authors:  Huiying Li; Thomas L Poulos
Journal:  Curr Top Med Chem       Date:  2004       Impact factor: 3.295

2.  Inhibition of recombinant cytochrome P450 isoforms 2D6 and 2C9 by diverse drug-like molecules.

Authors:  Daniel R McMasters; Rhonda A Torres; Susan J Crathern; Deborah L Dooney; Robert B Nachbar; Robert P Sheridan; Kenneth R Korzekwa
Journal:  J Med Chem       Date:  2007-06-09       Impact factor: 7.446

Review 3.  Mechanism-based inactivation of human cytochrome P450 enzymes: strategies for diagnosis and drug-drug interaction risk assessment.

Authors:  K Venkatakrishnan; R S Obach; A Rostami-Hodjegan
Journal:  Xenobiotica       Date:  2007 Oct-Nov       Impact factor: 1.908

4.  Drug interactions with calcium channel blockers: possible involvement of metabolite-intermediate complexation with CYP3A.

Authors:  B Ma; T Prueksaritanont; J H Lin
Journal:  Drug Metab Dispos       Date:  2000-02       Impact factor: 3.922

5.  A numerical method for analysis of in vitro time-dependent inhibition data. Part 1. Theoretical considerations.

Authors:  Swati Nagar; Jeffrey P Jones; Ken Korzekwa
Journal:  Drug Metab Dispos       Date:  2014-06-17       Impact factor: 3.922

6.  Prediction of midazolam-CYP3A inhibitors interaction in the human liver from in vivo/in vitro absorption, distribution, and metabolism data.

Authors:  K Yamano; K Yamamoto; M Katashima; H Kotaki; S Takedomi; H Matsuo; H Ohtani; Y Sawada; T Iga
Journal:  Drug Metab Dispos       Date:  2001-04       Impact factor: 3.922

7.  Mechanism-based inactivation of CYP3A by HIV protease inhibitors.

Authors:  C Steven Ernest; Stephen D Hall; David R Jones
Journal:  J Pharmacol Exp Ther       Date:  2004-11-02       Impact factor: 4.030

8.  Mechanism-based inactivation of human cytochrome p450 enzymes and the prediction of drug-drug interactions.

Authors:  R Scott Obach; Robert L Walsky; Karthik Venkatakrishnan
Journal:  Drug Metab Dispos       Date:  2006-11-08       Impact factor: 3.922

9.  The one-electron autoxidation of human cytochrome P450 3A4.

Authors:  Ilia G Denisov; Yelena V Grinkova; Mark A McLean; Stephen G Sligar
Journal:  J Biol Chem       Date:  2007-07-24       Impact factor: 5.157

10.  Microsomal metabolism of delavirdine: evidence for mechanism-based inactivation of human cytochrome P450 3A.

Authors:  R L Voorman; S M Maio; N A Payne; Z Zhao; K A Koeplinger; X Wang
Journal:  J Pharmacol Exp Ther       Date:  1998-10       Impact factor: 4.030

View more
  10 in total

1.  A numerical method for analysis of in vitro time-dependent inhibition data. Part 1. Theoretical considerations.

Authors:  Swati Nagar; Jeffrey P Jones; Ken Korzekwa
Journal:  Drug Metab Dispos       Date:  2014-06-17       Impact factor: 3.922

2.  Numerical Methods for Modeling Enzyme Kinetics.

Authors:  Jaydeep Yadav; Ken Korzekwa; Swati Nagar
Journal:  Methods Mol Biol       Date:  2021

3.  Multienzyme Kinetics and Sequential Metabolism.

Authors:  Larry C Wienkers; Brooke M Rock
Journal:  Methods Mol Biol       Date:  2021

4.  Numerical Analysis of Time-Dependent Inhibition by MDMA.

Authors:  John T Rodgers; Jeffrey P Jones
Journal:  Drug Metab Dispos       Date:  2019-10-22       Impact factor: 3.922

5.  Impact of Lipid Partitioning on the Design, Analysis, and Interpretation of Microsomal Time-Dependent Inactivation.

Authors:  Jaydeep Yadav; Ken Korzekwa; Swati Nagar
Journal:  Drug Metab Dispos       Date:  2019-05-01       Impact factor: 3.922

6.  Numerical analysis of time dependent inhibition kinetics: comparison between rat liver microsomes and rat hepatocyte data for mechanistic model fitting.

Authors:  Chuong Pham; Swati Nagar; Ken Korzekwa
Journal:  Xenobiotica       Date:  2017-06-23       Impact factor: 1.908

7.  Mechanism-Based Inhibition of CYP3A4 by Podophyllotoxin: Aging of an Intermediate Is Important for in Vitro/in Vivo Correlations.

Authors:  Carlo Barnaba; Jaydeep Yadav; Swati Nagar; Ken Korzekwa; Jeffrey P Jones
Journal:  Mol Pharm       Date:  2016-07-01       Impact factor: 4.939

8.  Improved Predictions of Drug-Drug Interactions Mediated by Time-Dependent Inhibition of CYP3A.

Authors:  Jaydeep Yadav; Ken Korzekwa; Swati Nagar
Journal:  Mol Pharm       Date:  2018-04-10       Impact factor: 4.939

Review 9.  Time-dependent enzyme inactivation: Numerical analyses of in vitro data and prediction of drug-drug interactions.

Authors:  Jaydeep Yadav; Erickson Paragas; Ken Korzekwa; Swati Nagar
Journal:  Pharmacol Ther       Date:  2019-12-11       Impact factor: 12.310

10.  Mechanisms of Herb-Drug Interactions Involving Cinnamon and CYP2A6: Focus on Time-Dependent Inhibition by Cinnamaldehyde and 2-Methoxycinnamaldehyde.

Authors:  Michael J Espiritu; Justin Chen; Jaydeep Yadav; Michael Larkin; Robert D Pelletier; Jeannine M Chan; Jeevan B Gc; Senthil Natesan; John P Harrelson
Journal:  Drug Metab Dispos       Date:  2020-08-12       Impact factor: 3.922

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.